Gastroenterology
Volume 133, Issue 3 , Pages 808-817 , September 2007

Neuropeptide S Receptor 1 Gene Polymorphism Is Associated With Susceptibility to Inflammatory Bowel Disease

  • Mauro D’Amato

      Affiliations

    • Strategic Research Center IRIS, Karolinska Institutet, Stockholm, Sweden
    • Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
    • Corresponding Author InformationAddress requests for reprints to: Mauro D’Amato, PhD, Department of Biosciences and Nutrition, Karolinska Institutet, Halsovagen 7-9, 14157 Stockholm, Sweden. fax: (46) 8-7745538.
    • ,
  • Sara Bruce

      Affiliations

    • Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden
    • ,
  • Francesca Bresso

      Affiliations

    • Strategic Research Center IRIS, Karolinska Institutet, Stockholm, Sweden
    • Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
    • ,
  • Marco Zucchelli

      Affiliations

    • Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden
    • ,
  • Sini Ezer

      Affiliations

    • Department of Medical Genetics, University of Helsinki, Helsinki, Finland
    • Folkhalsan Institute of Genetics, Helsinki, Finland
    • ,
  • Ville Pulkkinen

      Affiliations

    • Department of Medical Genetics, University of Helsinki, Helsinki, Finland
    • ,
  • Cecilia Lindgren

      Affiliations

    • Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden
    • ,
  • Marco Astegiano

      Affiliations

    • Clinic of Gastrohepatology DU, Molinette Hospital, Torino, Italy
    • ,
  • Mario Rizzetto

      Affiliations

    • Clinic of Gastrohepatology DU, Molinette Hospital, Torino, Italy
    • ,
  • Paolo Gionchetti

      Affiliations

    • Division of Internal Medicine, S. Orsola-Malpighi Hospital, Bologna, Italy
    • ,
  • Gabriele Riegler

      Affiliations

    • Gastroenterology Unit, 2nd University of Naples, Naples, Italy
    • ,
  • Raffaello Sostegni

      Affiliations

    • Gastroenterology Division, ASO Ordine Mauriziano, Torino, Italy
    • ,
  • Marco Daperno

      Affiliations

    • Gastroenterology Division, ASO Ordine Mauriziano, Torino, Italy
    • ,
  • Sandra D’Alfonso

      Affiliations

    • Department of Medical Sciences, University of Eastern Piedmont and IRCAD, Novara, Italy
    • ,
  • Patricia Momigliano–Richiardi

      Affiliations

    • Department of Medical Sciences, University of Eastern Piedmont and IRCAD, Novara, Italy
    • ,
  • Leif Torkvist

      Affiliations

    • Division of Colorectal Surgery, IBD Unit, Karolinska Institutet, Stockholm, Sweden
    • ,
  • Pauli Puolakkainen

      Affiliations

    • Department of Surgery, University of Helsinki, Helsinki, Finland
    • ,
  • Maarit Lappalainen

      Affiliations

    • Department of Medicine, University of Helsinki, Helsinki, Finland
    • Research program for Molecular Medicine, Biomedicum Helsinki, Helsinki, Finland
    • ,
  • Paulina Paavola–Sakki

      Affiliations

    • Department of Medicine, University of Helsinki, Helsinki, Finland
    • Department of Gastroenterology, University of Helsinki, Helsinki, Finland
    • ,
  • Leena Halme

      Affiliations

    • Department of Transplantation and Liver Surgery, University of Helsinki, Helsinki, Finland
    • ,
  • Martti Farkkila

      Affiliations

    • Department of Gastroenterology, University of Helsinki, Helsinki, Finland
    • ,
  • Ulla Turunen

      Affiliations

    • Department of Gastroenterology, University of Helsinki, Helsinki, Finland
    • ,
  • Kimmo Kontula

      Affiliations

    • Department of Medicine, University of Helsinki, Helsinki, Finland
    • ,
  • Robert Lofberg

      Affiliations

    • IBD Unit, HMQ Sophia Hospital, Stockholm, Sweden
    • Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    • ,
  • Sven Pettersson

      Affiliations

    • Strategic Research Center IRIS, Karolinska Institutet, Stockholm, Sweden
    • Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden
    • Genome Institute of Singapore, Singapore
    • ,
  • Juha Kere

      Affiliations

    • Department of Biosciences and Nutrition, Karolinska Institutet, Stockholm, Sweden
    • Department of Medical Genetics, University of Helsinki, Helsinki, Finland
    • Folkhalsan Institute of Genetics, Helsinki, Finland
    • J.K. is co-inventor on a patent application on NPSR1 (GPR154) owned by GenOs Ltd (Helsinki, Finland), and is a minority shareholder and member of the board of directors of GeneOs Ltd.

Received 20 August 2006 ,Accepted 25 May 2007.

References 

  1. Podolsky DK. Inflammatory bowel disease. N Engl J Med. 2002;347:417–429
  2. Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003;3:521–533
  3. Fedorak RN, Madson NL. Naturally occurring and experimental models of inflammatory bowel disease. In: 5th ed.. Philadelphia: Saunders; 2000;p. 113–143
  4. Schreiber S, Rosenstiel P, Albrecht M, et al. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet. 2005;6:376–388
  5. Kuster W, Pascoe L, Purrmann J, et al. The genetics of Crohn disease: complex segregation analysis of a family study with 265 patients with Crohn disease and 5,387 relatives. Am J Med Genet. 1989;32:105–108
  6. Orholm M, Munkholm P, Langholz E, et al. Familial occurrence of inflammatory bowel disease. N Engl J Med. 1991;324:84–88
  7. Meucci G, Vecchi M, Torgano G, et al. Familial aggregation of inflammatory bowel disease in northern Italy: a multicenter study. (The Gruppo di Studio per le Malattie Infiammatorie Intestinali (IBD Study Group)). Gastroenterology. 1992;103:514–519
  8. Tysk C, Lindberg E, Jarnerot G, et al. Ulcerative colitis and Crohn’s disease in an unselected population of monozygotic and dizygotic twins (A study of heritability and the influence of smoking). Gut. 1988;29:990–996
  9. Cho JH, Nicolae DL, Gold LH, et al. Identification of novel susceptibility loci for inflammatory bowel disease on chromosomes 1p, 3q, and 4q: evidence for epistasis between 1p and IBD1. Proc Natl Acad Sci U S A. 1998;95:7502–7507
  10. Hampe J, Schreiber S, Shaw SH, et al. A genomewide analysis provides evidence for novel linkages in inflammatory bowel disease in a large European cohort. Am J Hum Genet. 1999;64:808–816
  11. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn’s disease on chromosome 16. Nature. 1996;379:821–823
  12. Rioux JD, Silverberg MS, Daly MJ, et al. Genomewide search in Canadian families with inflammatory bowel disease reveals two novel susceptibility loci. Am J Hum Genet. 2000;66:1863–1870
  13. Satsangi J, Parkes M, Louis E, et al. Two stage genome-wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12. Nat Genet. 1996;14:199–202
  14. Gaya DR, Russell RK, Nimmo ER, et al. New genes in inflammatory bowel disease: lessons for complex diseases?. Lancet. 2006;367:1271–1284
  15. Laitinen T, Polvi A, Rydman P, et al. Characterization of a common susceptibility locus for asthma-related traits. Science. 2004;304:300–304
  16. Kormann MS, Carr D, Klopp N, et al. G-protein-coupled receptor polymorphisms are associated with asthma in a large German population. Am J Respir Crit Care Med. 2005;171:1358–1362
  17. Melen E, Bruce S, Doekes G, et al. Haplotypes of G protein-coupled receptor 154 are associated with childhood allergy and asthma. Am J Respir Crit Care Med. 2005;171:1089–1095
  18. Malerba G, Lindgren CM, Xumerle L, et al. Chromosome 7p linkage and GPR154 gene association in Italian families with allergic asthma. Clin Exp Allergy. 2007;37:83–89
  19. Feng Y, Hong X, Wang L, et al. G protein-coupled receptor 154 gene polymorphism is associated with airway hyperresponsiveness to methacholine in a Chinese population. J Allergy Clin Immunol. 2006;117:612–617
  20. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)). Methods. 2001;25:402–408
  21. Pulkkinen V, Majuri ML, Wang G, et al. Neuropeptide S and G protein-coupled receptor 154 modulate macrophage immune responses. Hum Mol Genet. 2006;15:1667–1679
  22. Vendelin J, Pulkkinen V, Rehn M, et al. Characterization of GPRA, a novel G protein-coupled receptor related to asthma. Am J Respir Cell Mol Biol. 2005;33:262–270
  23. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263–265
  24. Schaid DJ, Rowland CM, Tines DE, et al. Score tests for association between traits and haplotypes when linkage phase is ambiguous. Am J Hum Genet. 2002;70:425–434
  25. R Development Core Team. R Reference Manual: Base Package. Bristol: Network Theory. 2003.
  26. Benjamini Y, Hocgberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995;57:289–300
  27. Reinscheid RK, Xu YL, Okamura N, et al. Pharmacological characterization of human and murine neuropeptide s receptor variants. J Pharmacol Exp Ther. 2005;315:1338–1345
  28. Roth AL, Marzola E, Rizzi A, et al. Structure-activity studies on neuropeptide S: identification of the amino acid residues crucial for receptor activation. J Biol Chem. 2006;281:20809–20816
  29. Bernier V, Stocco R, Bogusky MJ, et al. Structure/function relationships in the neuropeptide s receptor: molecular consequences of the asthma-associated mutation N107I. J Biol Chem. 2006;281:24704–24712
  30. McGovern DP, Hysi P, Ahmad T, et al. Association between a complex insertion/deletion polymorphism in NOD1 (CARD4) and susceptibility to inflammatory bowel disease. Hum Mol Genet. 2005;14:1245–1250
  31. Brant SR, Panhuysen CI, Nicolae D, et al. MDR1 Ala893 polymorphism is associated with inflammatory bowel disease. Am J Hum Genet. 2003;73:1282–1292
  32. Ho GT, Nimmo ER, Tenesa A, et al. Allelic variations of the multidrug resistance gene determine susceptibility and disease behavior in ulcerative colitis. Gastroenterology. 2005;128:288–296
  33. Schwab M, Schaeffeler E, Marx C, et al. Association between the C3435T MDR1 gene polymorphism and susceptibility for ulcerative colitis. Gastroenterology. 2003;124:26–33
  34. Zheng W, Rosenstiel P, Huse K, et al. Evaluation of AGR2 and AGR3 as candidate genes for inflammatory bowel disease. Genes Immun. 2006;7:11–18
  35. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn’s disease. Nature. 2001;411:599–603
  36. Ogura Y, Bonen DK, Inohara N, et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn’s disease. Nature. 2001;411:603–606
  37. Hampe J, Cuthbert A, Croucher PJ, et al. Association between insertion mutation in NOD2 gene and Crohn’s disease in German and British populations. Lancet. 2001;357:1925–1928
  38. Stoll M, Corneliussen B, Costello CM, et al. Genetic variation in DLG5 is associated with inflammatory bowel disease. Nat Genet. 2004;36:476–480
  39. Peltekova VD, Wintle RF, Rubin LA, et al. Functional variants of OCTN cation transporter genes are associated with Crohn disease. Nat Genet. 2004;36:471–475
  40. Xu YL, Reinscheid RK, Huitron-Resendiz S, et al. Neuropeptide S: a neuropeptide promoting arousal and anxiolytic-like effects. Neuron. 2004;43:487–497
  41. Cookson W. The immunogenetics of asthma and eczema: a new focus on the epithelium. Nat Rev Immunol. 2004;4:978–988
  42. Sato S, Shintani Y, Miyajima N, et al. Novel G protein coupled receptor protein and DNA thereof. US patent application WO 02/31145 A1. April 18, 2002.
  43. Gupte J, Cutler G, Chen JL, et al. Elucidation of signaling properties of vasopressin receptor-related receptor 1 by using the chimeric receptor approach. Proc Natl Acad Sci U S A. 2004;101:1508–1513
  44. Vendelin J, Bruce S, Holopainen P, et al. Downstream target genes of the neuropeptide S-NPSR1 pathway. Hum Mol Genet. 2006;15:2923–2935
  45. O’Connor TM, O’Connell J, O’Brien DI, et al. The role of substance P in inflammatory disease. J Cell Physiol. 2004;201:167–180
  46. Papadakis KA. Chemokines in inflammatory bowel disease. Curr Allergy Asthma Rep. 2004;4:83–89
  47. Powrie F. Immune regulation in the intestine: a balancing act between effector and regulatory T cell responses. Ann N Y Acad Sci. 2004;1029:132–141
  48. Macdonald TT, Monteleone G. Immunity, inflammation, and allergy in the gut. Science. 2005;307:1920–1925
  49. Brogden KA, Guthmiller JM, Salzet M, et al. The nervous system and innate immunity: the neuropeptide connection. Nat Immunol. 2005;6:558–564
  50. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology. 2005;129:827–836
  51. Black H, Mendoza M, Murin S. Thoracic manifestations of inflammatory bowel disease. Chest. 2007;131:524–532

 Supported by funds from the Sigrid Jusélius Foundation (J.K. and K.K.), the Päivikki and Sakari Sohlberg Foundation and Academy of Finland (J.K. and K.K.), the Swedish Research Council (J.K. and S.P.), Italian Ministry of University and Research (PRIN project) (S.D. and P.M.-R.), and the KiiM Network (grant 2006 to M.D.).

PII: S0016-5085(07)01152-3

doi: 10.1053/j.gastro.2007.06.012

Gastroenterology
Volume 133, Issue 3 , Pages 808-817 , September 2007

Article Tools

* Image Usage & Resolution